NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015.20-08-2020
20-08-2020
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Notice of Postal Ballot14-08-2020
NEULAND LABORATORIES LTD. - 524558 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice dated August 4, 202013-08-2020
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith copies of the newspaper publication of Un-audited Financial Results for the quarter ended June 30, 2020, published in Financial Express and Andhra Prabha on August 5, 2020 for your reference.05-08-2020
Earnings Call Transcript - Q1FY21 for Neuland Laboratories
Conference Call with Neuland Labs Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.04-08-2020
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached a copy of the Press Release being issued by the Company along with Earnings PPT for the quarter ended June 30, 2020 and the same is being uploaded on the website of the Company. This is for your information and records.04-08-2020
NEULAND LABORATORIES LTD. - 524558 - Changes In Key Managerial Personnel
The Board in its meeting held today on August 4, 2020 has, inter alia, approved the following: - Re-designation of Dr. Davuluri Rama Mohan Rao as Executive Chairman of the Company, subject to the approval of the shareholders. - Re-designation of Mr. Davuluri Saharsh Rao as the Vice Chairman & Managing Director, subject to the approval of the shareholders. In addition, Mr. Davuluri Saharsh Rao shall be the Interim Chief Financial Officer of the Company from August 4, 2020 till Sept. 23, 2020. - Appointment of Mr. Deepak Gupta as the Chief Financial Officer with effect from September 24, 2020. This is for your information and records.04-08-2020
NEULAND LABORATORIES LTD. - 524558 - Outcome Of Board Meeting Held On August 4, 2020
Outcome of Board Meeting held on August 4, 202004-08-2020
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For Quarter Ended June 30, 2020
Unaudited Financial Results for quarter ended June 30, 202004-08-2020